Search 

OBIO, a not-for-profit, membership-based organization engaged in the development of and integrated health innovation economy for Ontario that will become a leader in providing health technology to the internatoinal marketplace. A key initiative is the OBIO Capital Access Advisory Programs (CAAP).  Led by OBIO and a North American Steering Committee including senior venture capitalists and seasoned entrepreneurs from MedImmune Ventures, Johns Hopkins, J&J, Genesys Capital, Lumira Capital, BDC Capital and Versant Ventures, we work with high-potential CAAP companies including those devloping therapeutics, med device, diagnostics and HIT products and services.